Matches 101 - 150 out of 354 < 1 2 3 4 5 6 7 8 >
Match Document Document Title
6284237 Methods of treatment using IL-6  
IL-6 is produced via recombinant DNA techniques. The peptide is useful in the treatment of disorders characterized by deficiencies in hematopoietic cells and in combination with other...
6280975 IL-6 mutein and DNA encoding thereto  
The present invention relates to a new IL-6 mutein, a DNA sequence coding for it, its use in therapy as well as a pharmaceutical composition comprising it. It is a potent IL-6 antagonist and can be...
6277598 DNA molecule encoding interferon-gamma (IFN-λ) inducing factor (IGIF, IL-18) and DNA fragment thereof  
A protein which induces the IFN-γ production by immunocompetent cells and has a molecular weight of 19,000±5,000 daltons on SDS-PAGE or gel filtration method and a pI of 4.8±1.0 on...
6274708 Mouse interleukin-11 receptor  
The present invention relates generally to novel haemopoietin receptors, or components or parts thereof and to a method for cloning genetic sequences encoding same. More particularly, the subject...
6274341 Cytostatic process increases the productivity of cultured cells  
Provided by the invention are novel methods, vectors and cells for the recombinant production of desired gene products. In particular, the invention relates to increased production of desired gene...
6268180 Recombinant human recombinant human interleukin-1α  
The invention relates to the cloning of the human interleukin-1α gene, its engineering into suitable expression vectors, hosts transformed with such expression vectors, and production of...
6238889 Molecular cloning and expression of the Pro8 isoform of human IL-3  
The invention relates to nucleotide sequences encoding human interleukin-3 (hIL-3) as well as recombinant DNAs, expression cassettes, transformed host cells, and recombinant expression methods...
6222027 Molecules expressed in hippocampus  
The invention provides novel developmentally-regulated hippocampal genes and polypeptides encoded by those genes. The invention also provides expression vectors, host cells, and antibodies. The...
6217857 Cytokine synthesis inhibitory factor (IL-10) and pharmaceutical compositions thereof  
Mammalian genes and proteins, designated cytokine synthesis inhibitory factors (CSIF's, now known as Interleukin-10 (IL-10)), are provided which are capable of inhibiting the synthesis of cytokines...
6214584 Human Interferon-γinducing factor  
A polypeptide which has a molecular weight of 18,500±3,000 daltons on SDS-PAGE and a pI of 4.9±1.0 on chromatofocusing. The polypeptide strongly induces the IFN-γ production by immunocompetent...
6207144 Polypeptides with interleukin-16 activity, process for the preparation and use thereof  
A nucleic acid which can be used to express a polypeptide with interleukin-16 activity in a prokaryotic or eukaryotic host cell, wherein in the region coding for the said polypeptide the said...
6200805 Materials and methods for screening human interleukin-4 antagonists/agonists  
Stably-transformed human cell lines containing a reporter gene operatively linked to an IL-4-responsive element are provided. In some embodiments a human Fc ε RII IL-4-responsive element is used....
6159463 Lymphocyte chemoattractant factor  
Purified DNA encoding LCF and the recombinant proteins expressed from such DNA are disclosed. In addition, the invention provides methods for suppressing an LCF-CD4 interaction and screening...
6156301 Use of interleukin-7 to stimulate proliferation of hematopoietic cell precursors  
Mammalian Interleukin-7 proteins (IL-7s), DNAs and expression vectors encoding mammalian IL-7s, and processes for producing mammalian IL-7s as products of cell culture, including recombinant...
6153409 Process for continuous optimized protein production in insect larvae  
The present invention provides for a recombinant insect larvae and a process of manufacturing proteins utilizing insect larvae that allows for the selection of individual larvae for harvest at the...
6132991 Human interleukin-3 (IL-3) variant fusion proteins  
The present invention relates to fusion molecules composed of human interleukin-3 (hIL-3) variant or mutant proteins (muteins) functionally joined to a second colony stimulating factor (CSF),...
6074639 Ex vivo expansion of hematopoietic cells using interleukin-3 (IL-3) variant fusion proteins  
The present invention relates to fusion molecules composed of human interleukin-3 (hIL-3) variant or mutant proteins (muteins) functionally joined to a second colony stimulating factor (CSF),...
6066317 Method of using IL-11 for treating deficiencies in hematopoietic progenitor or stem cells  
A novel mammalian cytokine, IL-11, and processes for producing it are disclosed. IL-11 may be used in pharmaceutical preparations for stimulating and/or enhancing cells involved in the immune...
6063600 DNA encoding canine interleukin-1 receptor antagonist  
Canine IL-1 receptor antagonist protein, DNAs, and expression vectors carrying DNA sequence encoding canine IL-1 receptor antagonist are disclosed.
6060284 DNA encoding interleukin-B30  
Purified genes encoding cytokines from a mammal, reagents related thereto including purified proteins, specific antibodies, and nucleic acids encoding this molecule are provided. Methods of using...
6060283 Genomic DNA encoding human interleukin-18 (IL-18, interferon-γ inducing factor)  
Disclosed is a genomic DNA encoding a polypeptide capable of inducing the production of interferon-γ by immunocompetent cells. The genomic DNA efficiently expresses the polypeptide with high...
6057133 Multivariant human IL-3 fusion proteins and their recombinant production  
The present invention relates to fusion molecules composed of human interleukin-3 (hIL-3) variant or mutant proteins (muteins) functionally joined to a second colony stimulating factor (CSF),...
6051217 Therapeutic uses of interleukin-3 (IL-3) multiple mutation polypeptides  
The present invention relates to recombinant human interleukin-3 (hIL-3) variant or mutant proteins (muteins). These hIL-3 muteins contain amino acid substitutions and may also have amino acid...
6046035 Polynucleotides encoding a cardiotrophin-like cytokine  
The present invention relates to a novel CLC protein which is a member of the IL-6 cytokine family. In particular, isolated nucleic acid molecules are provided encoding the human CLC protein. CLC...
6037149 DNA encoding human asthma associated factor 1  
A C to T DNA variation at position 3365 in exon 5 of the human Asthma Associated Factor 1 (AAF1) produces the predicted amino acid substitution of a methionine for a threonine at codon 117 of AAF1....
6030812 Fusion proteins comprising multiply mutated interleukin-3 (IL-3) polypeptides and second growth factors  
The present invention relates to human interleukin-3 (hIL-3) variant or mutant proteins (muteins) fused with other colony stimulating factors (CSF), cytokines, lymphokines, interleukins,...
5997857 Co-administration of interleukin-3 mutants with colony stimulating factors  
The present invention relates to human interleukin-3 (hIL-3) variant or mutant proteins (muteins) functionally co-administered with other colony stimulating factors (CSF), cytokines, lymphokines,...
5994104 Interleukin-12 fusion protein  
This invention relates to Interleukin-12 fusion proteins and nucleic acid constructs encoding them, and to the use of such fusion proteins and constructs in tumour therapy, especially therapy of...
5989867 DNA encoding IL-10-like homologue; related reagents  
Purified genes encoding cytokine from a mammal, reagents related thereto including purified proteins, specific antibodies, and nucleic acids encoding this molecule are provided. Methods of using...
5985614 Polynucleotides encoding interleukin-19  
The present invention concerns a novel human cytokine. In particular, isolated nucleic acid molecules are provided encoding interleukin-19 (IL-19). IL-19 polypeptides are also provided, as are...
5972902 DNA encoding human IL-6 receptor antagonist and protein encoded thereby  
The present invention relates to human interleukin-6 receptor antagonists which are incapable of binding to the receptor chain responsible for transduction of the signal associated with...
5968735 Vector for the expression of therapy-relevant genes  
A vector for expression of relevant therapeutic genes in mammalian cells which utilizes the mdr promoter, and optionally, the mdr enhancer, operably linked to the therapeutic gene.
5965404 Method for introducing nucleic acids into higher eukaryotic cells  
Process and medium for the transfection of higher eukaryotic cells with DNA/polycation complexes, wherein a medium is used which contains ethyleneglycol and/or glycerol. The medium may also contain...
5962268 DNA encoding an immune cell cytokine  
Human Immune Cell Cytokine-like Hormone polypeptide and DNA (RNA) encoding such polypeptide in a procedure for producing such polypeptides by recombinant techniques is disclosed. Also disclosed are...
5958400 Interleukin-6 splice variant  
Polynucleotides which encode the polypeptide IL-6SV, as well as such polypeptides, antibodies and antagonist inhibitors against the polypeptide and the use of the polypeptide as a pharmaceutical...
5955315 Nucleic acids encoding human interleukin-4  
Mammalian proteins and muteins thereof, designated interleukin-4s (IL-4s), are provided which exhibit both B cell growth factor activity and T cell growth factor activity. Compounds of the...
5951973 Use of interleukin-4 (IL-4) to treat rheumatoid arthritis  
A method of treating rheumatoid arthritis comprising administering human Interleukin-4 (IL-4) to an individual afflicted with the disease. The IL-4 is administered with a pharmaceutically...
5945310 DNA encoding members of the IL-1 family, IL-1 delta  
IL-1 delta polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing IL-1 delta peptides are...
5939288 Plant secretory signal peptides and nectarins  
Provided herein are signal peptides, and constructs and vectors having signal peptides, as well as methods of using signal peptides to deliver proteins into secretory material. The invention...
5935569 Genetic anticancer vaccine  
Genetic anticancer vaccine for stimulation of patient's immune system to eradicate cancer, particularly malignant melanoma. The objective of the invention is genetic modification of allogeneic...
5935789 Autonomously replicating sequences, GAPDH gene and promoter derived from Hansenula polymorpha, expression vectors containing same and method for the selection of transformants  
Autonomously replicating sequences(ARS), glyceraldehyde-3-phosphate dehydrogenase(GAPDH) gene and GAPDH promoter derived from Hansenula polymorpha DL-1(ATCC 26012); a vector for H. polymorpha which...
5936066 Recombinant human interleukin-1α  
The invention relates to the cloning of the human IL-1 gene, its engineering into suitable expression vectors, transformation of host organisms with such expression vectors and production of...
5928917 Conjugate of non-protein chemical moiety and polypeptide having cellulose binding region  
Fusion proteins or conjugates are provided containing an amino acid sequence having a substrate binding region of a polysaccharidase such as cellulase that binds to a β-1,4-glycan matrix such as...
5922573 IL-1 receptor antagonists with enhanced inhibitory activity  
DNA molecules that code for IL-1 antagonists with improved biological activity arc described. DNA molecules coding for improved IL-1 antagonists inserted into expression vectors and host cells...
5914106 Interleukin-6 receptor agonists  
It is known that the ligands of the group of cytokines similar to Interleuk 6 (IL-6), that is Oncostatin M (OSM), Leukemia Inhibitory Factor (LIF), Ciliary Neurotrophic Factor (CNTF) and...
5914253 Recombinant production of murine interferon--γ (IFN-γ) inducing factor (IGIF, IL-18)  
DNA encoding a murine protein capable of inducing the production of interferon-γ by immunocompetent cells is described. The native protein from mouse liver has a molecular weight of 19±5 kDa, a...
5897990 Assays for measuring immunosuppressants by reporter gene expression  
Quantitative reporter gene assays allowing for highly precise measurements of immunosuppressants in bodily fluids are provided, e.g., an IL-2 reporter gene assay for measuring blood levels of...
5891680 Bioactive fusion proteins comprising the p35 and p40 subunits of IL-12  
Fusion proteins, such as a bio active IL-12 polypeptide, which comprise at least two polypeptide monomers (chains of amino acids) joined through a heterologous polypeptide linker and which are...
5891998 Interleukin-6 receptor agonists  
Disclosed are interleukin-6 receptor agonists. These receptor agonists were enerated by mutating amino acid positions 175, 176, 177, 181, and/or 183 of human interleukin-6.
5889190 Recombinant plant viral nucleic acids  
The present invention is directed to recombinant plant viral nucleic acids and to hosts infected thereby. The recombinant plant viral nucleic acids comprise a native plant viral subgenomic...
Matches 101 - 150 out of 354 < 1 2 3 4 5 6 7 8 >